The MIHARI project: establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan

Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):854-9. doi: 10.1002/pds.4032. Epub 2016 May 25.

Authors

Chieko Ishiguro¹, Yoshinori Takeuchi¹, Yoshiaki Uyama¹, Tomiko Tawaragi¹

Affiliation

¹ Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.

PMID: 27222073
DOI: 10.1002/pds.4032

No abstract available

Keywords: pharmacoepidemiology; post-marketing drug safety; regulatory science.

MeSH terms

Databases, Factual
Drug Prescriptions / standards
Drug-Related Side Effects and Adverse Reactions / epidemiology*
Electronic Health Records
Equipment and Supplies* / adverse effects
Equipment and Supplies* / standards
Humans
Japan / epidemiology
Pharmaceutical Preparations / standards*
Pharmacoepidemiology / methods*
Pilot Projects

Substances

Pharmaceutical Preparations